Related Experiment Video
Updated: Jul 9, 2026
10:22
Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
Published on: September 16, 2011
Paclitaxel hypersensitivity reactions related to bee-sting allergy
Lancet (London, England)
|February 16, 2000
Summary
Patients with a history of bee sting allergy face increased hypersensitivity risks during paclitaxel treatment. Thorough allergy screening is recommended before initiating this chemotherapy.
Area of Science:
- Oncology
- Allergy and Immunology
Background:
- Paclitaxel is a widely used chemotherapy agent.
- Hypersensitivity reactions (HSRs) are a known risk with paclitaxel administration.
Discussion:
- Patients with a history of severe allergic reactions, such as to bee stings, may exhibit heightened susceptibility to paclitaxel-induced HSRs.
- Cross-reactivity between hymenoptera venom allergens and paclitaxel components is a potential mechanism.
Key Insights:
- Pre-existing bee sting allergy is a significant risk factor for paclitaxel hypersensitivity.
- Proactive patient screening for specific allergies is crucial.
Outlook:
- Further research is warranted to elucidate the immunological mechanisms underlying this association.
- Developing improved HSR prevention and management strategies for at-risk patients is essential.
Related Concept Videos
00:42Cross-reactivity
Overview
02:06Allergic Reactions
Overview
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
01:19Hypersensitivity Reactions: Immune-Complex Reactions
Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...